Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 0093-7384

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 0093-7384). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Pharmacokinetic (PK) fold change graph presenting the impact of various interacting drugs such as Ethanol, Diazepam, Cimetidine, Ketoconazole, Indinavir, Metoprolol, Imipramine, and Lithium on venlafaxine and its ODV metabolite. The chart plots Cmax and AUC values with 90% confidence intervals and includes dosage adjustment recommendations relative to the reference value.*

FDA Label Image

Image 2

A pharmacokinetic bar graph presenting the effect of various interacting drugs on the maximum concentration (Cmax) and area under the curve (AUC) of venlafaxine hydrochloride. It displays fold changes relative to reference values, with recommendations for dose adjustments or cautions for each interacting drug, such as ethanol, diazepam, alprazolam, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium.*

FDA Label Image

Image 3

A scatter plot chart showing fold change and 90% confidence intervals in pharmacokinetic parameters (Cmax, AUC) of venlafaxine and its metabolite ODV across special populations, including hepatic and renal impairment, CYP2D6 metabolizer status, age over 60 years, and gender. The x-axis represents change relative to a reference value, with recommendations on dose adjustments presented alongside.*

FDA Label Image

Image 4

Chemical structure of venlafaxine hydrochloride showing its molecular arrangement including a methoxyphenyl group, cyclohexanol ring, and dimethylaminoethyl side chain, with a hydrochloride component indicated.*

FDA Label Image

Image 5

Label for Venlafaxine Hydrochloride Extended-release Capsules, USP in 37.5 mg strength. The label includes the National Drug Code (NDC 0093-7384-56), states the package contains 30 capsules, and is labeled for oral use. It is manufactured by Teva Pharmaceuticals USA, Inc. The label also notes it is sealed for protection and directs pharmacists to dispense the accompanying Medication Guide.*

FDA Label Image

Image 6

Label for Venlafaxine Hydrochloride Extended-release Capsules, USP, 75 mg strength by Teva Pharmaceuticals USA, Inc. The label indicates the product is sold in a package containing 30 capsules, for oral use. The NDC number shown is 0093-7385-56, and the label includes a barcode and a serialization coding area.*

FDA Label Image

Image 7

Label for Venlafaxine Hydrochloride Extended-release Capsules, USP 150 mg by Teva Pharmaceuticals USA, Inc. The label indicates the product is a human prescription drug in extended-release capsule form, oral route. The package contains 30 capsules and includes dispensing instructions for pharmacists and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.